BS148
BS148 is a selective sigma-2 receptor (S2R) agonist with a Ki 20 nM. BS148 shows >80-fold selective for S2R than S1R. BS148 activates the endoplasmic reticulum stress response through the upregulation of protein kinase R-like ER kinase (PERK), activating transcription factor 4 (ATF4) genes, and C/EBP homologous protein (CHOP). BS148 induces apoptosis in melanoma cell. BS148 downregulates genes related to the cholesterol pathway and activates the MAPK signaling pathway. BS148 can be used for the study of melanoma.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2162116-09-6
- 分子式: C21H31NS2
- 分子量:361.61
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
Sigma Receptor アイソフォーム固有の製品をすべて表示
More
生物活性
|
Sigma 2 Receptor 20 nM (Ki) |
Sigma 1 Receptor 540 nM (Ki) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| SK-MEL-28 | IC50 |
22 μM
Compound: 10
|
Anti-proliferative against human SK-MEL-28 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Anti-proliferative against human SK-MEL-28 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 36202063] |
| SK-MEL-28 | IC50 |
52 μM
Compound: 10
|
Anti-proliferative against human SK-MEL-28 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
Anti-proliferative against human SK-MEL-28 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
|
[PMID: 36202063] |
化学情報
-
CAS 番号 2162116-09-6
-
分子量 361.61
-
分子式 C21H31NS2
-
SMILES
N1(CC2SC3(CCCCC3)SC2)CCC(CC4=CC=CC=C4)CC1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Claudia Sorbi, et al. BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting. Int J Mol Sci. 2023 Jun 2;24(11):9684. [Content Brief]
[2]. Franchini S, et al. Structure-Activity Relationships within a Series of σ1 and σ2 Receptor Ligands: Identification of a σ2 Receptor Agonist (BS148) with Selective Toxicity against Metastatic Melanoma. ChemMedChem. 2017 Nov 22;12(22):1893-1905. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
BS148 関連分類
HY-121033 関連分類
Powered by Bioz